Ignite Creation Date:
2025-12-25 @ 4:05 AM
Ignite Modification Date:
2025-12-26 @ 3:00 AM
Study NCT ID:
NCT06699602
Status:
RECRUITING
Last Update Posted:
2025-10-14
First Post:
2024-11-19
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study of Cemiplimab and Fianlimab in People With Clear Cell Renal Cell Carcinoma
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-02-11
Start Date Type:
ACTUAL
Primary Completion Date:
2028-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-02
Completion Date Type:
ESTIMATED
First Submit Date:
2024-11-19
First Submit QC Date:
None
Study First Post Date:
2024-11-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-10
Last Update Post Date:
2025-10-14
Last Update Post Date Type:
ESTIMATED